Clinical Trial Update: Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics? [NA]

View source ↗

Summary

This clinical trial update examines whether CYP2C9 polymorphism affects pharmacokinetics and pharmacodynamics in hypertension, based on a study sponsored by Ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Hypertension | NA | Status: UNKNOWN